“We continue to be amazed by the many benefits of a HFLC ketogenic diet. Its use in Alzheimers, cancer, diabetes, weight management, athletic performance and even bio-hackers has seen the keto market explode,” said Neal Mercado, vice president of marketing and innovation at DFH, “and with its significant benefits to our practitioner customers and their patients, we decided to lead and disrupt the category by developing products with superior ingredients, novel formulations, and multiple occasion uses to support a ketogenic lifestyle.” Mercado added that, “DFH has always been ahead of the curve when it comes to innovation, and using Allulose, which has no impact on blood glucose levels and 1/10th the calories of sugar, is no exception. In fact, we have been formulating with it since 2017.”
The latest development in the sweetener market could not have come at a better time for DFH. “We were finalizing the packaging when the news broke on April 17, and were able to quickly pivot to change copy in line with the new FDA enforcement discretion,” stated Mercado. The FDA draft guidelines now allow Allulose to be excluded from the total and added sugars declarations on the Nutrition Facts panel, so, both manufacturers and consumers benefit from clearer product labeling.
The KTO-360 line, as with all DFH products, began with research-driven ingredients to achieve successful health outcomes. “We realized that for many people a Keto diet is a therapeutic necessity, so we approached this new line development in the same way we would any of our new product launches,” commented Jason Bosley-Smith, MS, LDN, CNS, FDN Director, Education at DFH.
Three healthy fats and collagen are the foundation of the line:
- C8 (caprylic acid MCTs) to maximize the production of ketones
- Coconut Oil rich in monosaturated (oleic) and polyunsaturated fatty (Linolenic) acids
- Grass-fed Butter (rBST free) rich in monosaturated (oleic) and saturated fatty acids as well as a rich source of butyrate
- Collagen – a unique blend of three patented forms of collagen: Verisol, Fortigel, and Fortibone each with supported published clinical data
According to Mordor Intelligence, the ketogenic diet food market was valued at USD 9.08 billion in 2018 and is expected to reach $12.35 billion in 2024, at an estimated CAGR of 5.3%, during the forecast period.